Horn A, Sherman E, Lee N, Yu Y, et al. A Phase 2 Study of Postoperative Xevinapant and Chemoradiation for Patients With High-Risk Resected Head and Neck Squamous Cell Carcinomas. Int J Radiat Oncol Biol Phys 2026 Sep 17:S0360-3016(26)04231.
PMID: 42808934